Document is current
Any future updates will be listed below
-
Authors
Yuasa, Taichi
Tokuda, Yuichi
Nakano, Masakazu
Tashiro, Kei
Tourtas, Theofilos
Schlötzer-Schrehardt, Ursula
Kruse, Friedrich
Koizumi, Noriko
Okumura, Naoki
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (21K06840, 18K09464)
Japan Agency for Medical Research and Development (JP22ek0109590)
- License Information
-
More Information
Article History
Received: 29 November 2024
Accepted: 25 February 2025
First Online: 26 April 2025
Declarations
:
: Naoki Okumura and Noriko Koizumi are co-founders of ActualEyes Inc., which is currently developing a pharmaceutical therapy for treating Fuchs endothelial corneal dystrophy. However, these affiliations did not influence the design, execution, interpretation, or reporting of the research presented in this paper. Other authors do not have a competing financial interest.
